Guinea pig 11β-hydroxysteroid dehydrogenase type 1:: primary structure and catalytic properties

被引:19
|
作者
Pu, X
Yang, K
机构
[1] Univ Western Ontario, St Josephs Hlth Ctr, Lawson Res Inst, Dept Obstet & Gynecol, London, ON N6A 4V2, Canada
[2] Univ Western Ontario, St Josephs Hlth Ctr, Lawson Res Inst, Dept Physiol, London, ON N6A 4V2, Canada
基金
英国医学研究理事会;
关键词
11; beta-HSD1; cDNA and protein sequence; mRNA; enzyme properties; guinea pigs; glucocorticoid resistance;
D O I
10.1016/S0039-128X(99)00098-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) enzyme is responsible for the interconversion of glucocorticoids and their inactive metabolites, and thus modulates the intracellular level of bioactive glucocortisoids. The present study was designed to clone and characterize 11 beta-HSD1 in the guinea pig, a laboratory animal known for resistance to glucocorticoids. The cDNA encoding guinea Pie 11 beta-HSD1 was cloned by a modified 3'-RACE (rapid amplification of cDNA ends) protocol using the hepatic RNA as template. The cloned cDNA encodes a protein of 300 amino acids that shares 71 to 74% sequence identity with other known mammalian 11 beta-HSD1 plateins. Sequence comparison analysis revealed that the deduced guinea pig 11 beta-HSD1 was longer. by eight amino acids at the C terminus, than those of other mammals. Moreover, one of the two absolutely conserved consensus sites for N-glycosylation was absent. To examine the functional significance of these structural changes, we also characterized 11 beta-HSD1 activity in the hepatic microsomes. Although the guinea pig hepatic enzyme was NADP(H)-dependent and reversible, it displayed equal affinity fur cortisol and cortisone (apparent K-m fur both substrates was 3 mu M). This is in marked contrast to 11 beta-HSD1 in other rnnmmals whose affinity for cortisone is approximately 10 times higher than thar for cortisol (apparent K-m of 0.3 vs. 3.0 mu M). The apparent lower affinity of the guinea pig enzyme for cortisone would suggest that the intracellular bioformation of cortisol from circulating cortisone may he less efficient in this species. Northern blot analysis and RT-PCR revealed that the mRNA Tot 11 beta-HSD1 was widely expressed in the adult guinea pig but at low amounts. In conclusion, the present study has identified distinct features in the deduced primary structure and catalytic function of 11 beta-HSD1 in the guinea pig. Thus, the guinea pig provides a useful model in which the structural determinants of catalytic function of 11 beta-HSD1 may be: studied. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:148 / 156
页数:9
相关论文
共 50 条
  • [41] Role of 11β-hydroxysteroid dehydrogenase type 1 in the development of atopic dermatitis
    Lee, Noo Ri
    Kim, Beom Jun
    Lee, Chung Hyeok
    Lee, Young Bin
    Lee, Solam
    Hwang, Hyun Jee
    Kim, Eunjung
    Kim, Sung Hee
    Lee, Min-Geol
    Lee, Sang Eun
    Lavery, Gareth G.
    Choi, Eung Ho
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [42] 11β-hydroxysteroid dehydrogenase type 1 inhibitors: a review of recent patents
    Boyle, Craig D.
    Kowalski, Timothy J.
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (06) : 801 - 825
  • [43] Postnatal development of 11β-hydroxysteroid dehydrogenase type 1 in the rat hippocampus
    Wan, SL
    Liao, MY
    Sun, K
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 69 (05) : 681 - 686
  • [44] Structural assessment and identification of 11β-hydroxysteroid dehydrogenase type 1 inhibitors
    Ganjoo, Ananta
    Tripathi, Anuj
    Chetti, Prabhakar
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2020, 38 (16): : 4928 - 4937
  • [45] Absence of type 1 11β-hydroxysteroid dehydrogenase enzyme in koala liver
    Kong, S
    McKinnon, RA
    Mojarrabi, B
    Stupans, I
    [J]. COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY, 2002, 131 (01): : 39 - 50
  • [46] The role and regulation of 11β-hydroxysteroid dehydrogenase type 1 in the inflammatory response
    Chapman, Karen E.
    Coutinho, Agnes E.
    Gray, Mohini
    Gilmour, James S.
    Savill, John S.
    Seckl, Jonathan R.
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 301 (1-2) : 123 - 131
  • [47] Discovery of novel inhibitors of human 11β-hydroxysteroid dehydrogenase type 1
    Su, Xiangdong
    Vicker, Nigel
    Trusselle, Melanie
    Halem, Heather
    Culler, Michael D.
    Potter, Barry V. L.
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 301 (1-2) : 169 - 173
  • [48] Substituted adamantanamides as novel inhibitors of 11β-hydroxysteroid dehydrogenase type 1
    Linders, Joannes T. M.
    Willemsens, Gustaaf H. M.
    Bellens, Danny
    Buyck, Christophe
    De Backker, Peter
    Ethirajulu, Kantharaj
    Gilissen, Ron A. H. J.
    Hrupka, Brian
    Jaroskova, Libuse
    Van Lommen, Guy
    Meulemans, Ann
    Smans, Karine
    van Dorsselaer, Pascal
    Van der Veken, Louis
    Berwaer, Monique
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [49] Reduced 11β-hydroxysteroid dehydrogenase type 1 activity in obese boys
    Wiegand, Susanna
    Richardt, Anna
    Remer, Thomas
    Wudy, Stefan A.
    Tomlinson, Jeremy W.
    Hughes, Beverly
    Grueters, Annette
    Stewart, Paul M.
    Strasburger, Christian J.
    Quinkler, Marcus
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2007, 157 (03) : 319 - 324
  • [50] Medicinal Chemistry of Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1)
    Scott, James S.
    Goldberg, Frederick W.
    Turnbull, Andrew V.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (11) : 4466 - 4486